The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: A prospective, single-arm, phase II trial.
 
Shengjie Sun
No Relationships to Disclose
 
Xiao Zhao
No Relationships to Disclose
 
Jing Zhang
No Relationships to Disclose
 
Lupeng Qiu
No Relationships to Disclose
 
Quanli Han
No Relationships to Disclose
 
Xiang Yan
No Relationships to Disclose
 
Yanyun Zhu
No Relationships to Disclose
 
Jinliang Wang
No Relationships to Disclose
 
Xiaoling Zhang
No Relationships to Disclose
 
Shunchang Jiao
No Relationships to Disclose